Biologics are a popular treatment option for moderate to severe psoriasis, and many people in the community have experience with them. Here are some of the most commonly used biologics:
TNF Inhibitors:
- Adalimumab (Humira)
- Certolizumab (Cimzia)
- Etanercept (Enbrel)
- Infliximab (Remicade)
IL Inhibitors
- Brodalumab Show Full Answer
Biologics are a popular treatment option for moderate to severe psoriasis, and many people in the community have experience with them. Here are some of the most commonly used biologics:
TNF Inhibitors:
- Adalimumab (Humira)
- Certolizumab (Cimzia)
- Etanercept (Enbrel)
- Infliximab (Remicade)
IL Inhibitors:
- Brodalumab (Siliq)
- Guselkumab (Tremfya)
- Ixekizumab (Taltz)
- Secukinumab (Cosentyx)
- Ustekinumab (Stelara) As for cost, biologics can run anywhere from $22,000 to $54,000 per year — yes, that's a lot! But don't panic just yet.
Here are some ways to help manage the cost:
- Insurance coverage — Most plans cover biologics, but you may need prior authorization
- Manufacturer assistance programs — Drug makers often offer copay help
- Biosimilars — These are FDA-approved versions modeled after brand-name biologics and are typically less expensive, with no clinical differences in safety or effectiveness A MyPsoriasisTeam member shared, "I started using biologics because I was more afraid of what would happen to my body if I didn't control the damage. We all make the call for ourselves."
It's always worth having a detailed conversation with your dermatologist and insurance provider to find the best and most affordable option for your situation.
August 3
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
